LYME DISEASE BIOBANK FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$280,534
Cash & Equivalents
95%
Receivables (Non-Related)
5%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$299,525
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$63,785
$266,113
+317%
Receivables (Non-Related)
$13,618
$14,421
+6%
Related-Party Receivables
$0
-
-
Inventories
$0
-
-
Prepaid Expenses
$0
-
-
Investments
$0
-
-
Property, Plant, & Equipment (net)
$0
-
-
Other Assets
$0
-
-
Total Assets
$77,403
$280,534
+262%
Liabilities
2023
2024
Change
Payables & Accruals
$63,091
$299,525
+375%
Grants Payable
$0
-
-
Deferred Revenue
$0
-
-
Tax-Exempt Bond Liabilities
$0
-
-
Custodial & Escrow Liabilities
$0
-
-
Notes Payable / Debt (Non-Related)
$0
-
-
Related-Party Payables
$0
-
-
Other Liabilities
$0
-
-
Total Liabilities
$63,091
$299,525
+375%
Net assets
2023
2024
Change
Restricted Net Assets
$0
-
-
Unrestricted Net Assets
$14,312
-$18,991
-233%
Net assets
2023
2024
Change
Net assets
+$14,312
-$18,991
-233%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)